HMGB1 expression is typically higher in prostate cancer cells undergoing metastasis [34] and its expression exhibited a positive correlation with clinicopathological characteristics among prostate cancer patients concluding its prognostic relevance [35, 36]. This evidence concerns the gene HMGB1 and prostate carcinoma.